Kristen Rhodin

Journal Article Surg Oncol Clin N Am · July 2025 In-transit (IT) melanoma represents a distinct, heterogeneous pattern of disease that arises as superficial tumors along the track between the primary site and the draining regional lymph node basin. Many therapies have been explored for treatment of this ... Full text Link to item Cite

Circulating Tumor DNA in High-Risk Stage II/III Cutaneous Melanoma: A Feasibility Study.

Journal Article Ann Surg Oncol · July 2025 BACKGROUND: Adjuvant therapies reduce recurrence in patients with clinical stage IIB/IIC/III melanoma; however, better risk stratification and patient selection are needed. Circulating tumor DNA (ctDNA) as a marker of micrometastatic residual disease is be ... Full text Link to item Cite

ASO Author Reflections: Circulating Tumor DNA in High-Risk Resected Melanoma: Is there a Role?

Journal Article Ann Surg Oncol · July 2025 Full text Link to item Cite

View All Publications